(Anoxomat, Mart Microbiology B.V., Drachten, the Netherlands). Culture medium was supplemented with kanamycin (50 mg l À1 ) or chloramphenicol (10 mg l À1 ), where required. We knocked out the sodB and katA genes with suicide plasmids as described previously. 8 Briefly, a DNA fragment containing sodB and its flanking region was amplified from C. jejuni NCTC 11168 using the primers sodB_F: GAC TTA TAT CAA GGC TGG GAT TAT TGA and sodB_R: CAC TCC ATT TCC ACA ACC AAA ATC AAG T, and was ligated to pUC19. The chloramphenicol resistance cassette (cat) was PCR-amplified from pRY112, 9 and inserted into a BglII site of sodB in pUC19. To construct a katA mutant, the PCR product amplified with the primers (katA_F: TAA CGA TTT TGG ATC CAT TAT AGC and katA_R: AAT TAT TTT TCT AAA GCT TTT TTA ATT CC) was cloned to pUC19. The kanamycin resistance cassette (aphA) was generated by PCR from pMW10, 10 and inserted to a BglII site of katA on pUC19. The constructed suicide plasmids were introduced to C. jejuni NCTC 11168 by electroporation. The sodB and katA mutants were selected by growing on MH agar plates supplemented with chloramphenicol (10 mg l À1 ) and kanamycin (50 mg l À1 ), respectively. The sodB and katA double mutant was constructed by transferring the sodB mutation to the katA mutant by natural transformation. 8 To construct complementation strains, intact copies of sodB and katA were integrated into the chromosome with a method described elsewhere. 11 Briefly, DNA fragments containing the intact copy of sodB and katA were amplified with primer pairs (sodB-CF: GAT TAA ATA TCT AGA AAT TTT ACC CAC and sodB-CR: CCC TTT TTG TCT AGA ATG TTG AC and katA-CF: TTT TGA AAT TTA TTA TCT AGA AAA TGC AAT TAT TC and katA-CR: TTA TTA TAA TCT CTA GAT TGC CAC CAA AAG) and cloned into an XbaI site of a pUC19 derivative carrying an rRNA gene cluster. [11] [12] [13] The plasmids were delivered to the sodB and katA mutants by electroporation. Allelic exchanges in the sodB and katA mutants were confirmed by PCR and sequencing a flanking region of the mutated genes (data not shown). The minimum inhibitory concentrations (MICs) of several antibiotics (ciprofloxacin, erythromycin, cefotaxime, gentamicin, rifampicin, polymyxin B and tetracycline) were measured with the microtitre broth dilution method. 14 Rapid killing of Campylobacter by antibiotics was determined as described previously with some minor modifications. 9 Briefly, C. jejuni grown overnight on MH agar plates was resuspended in fresh MH broth to an OD at 600 nm of B0.06 (10 7 CFU ml À1 ). Aliquots of bacterial suspension were exposed to antibiotics. At every 1 h, samples were serially diluted and applied to MH agar plates for viable counts.
The katA mutation decreased the MICs of ciprofloxacin and rifampicin by two-fold compared with the wild-type. The MIC reduction in ciprofloxacin was restored by complementation, while that of rifampicin was not complemented (data not shown). Although the sodB single mutation did not make any differences in the MICs of the tested antibiotics, the sodB and katA double mutation further decreased the MICs of rifampicin and cefotaxime by four-and twofold, respectively (data not shown). In E. coli, similarly, single mutations of kat and sod genes did not affect MIC levels but a katG and katE double mutation reduced the MIC of norfloxacin by two-fold. 9 To examine lethality kinetics, C. jejuni was exposed to 10 times the MICs of ciprofloxacin and rifampicin, and bacterial viability was determined. Interestingly, the mutants in the oxidative stress defense system demonstrated significantly reduced viability compared with the wild-type (Figure 1) . Overall, the viability reduction was more significant in the katA mutant compared with the sodB mutant, and bacterial killing was synergistically enhanced by the sodB and katA double mutation particularly under rifampicin treatment (Figure 1b) . Similarly, it was reported that a sodA mutation in E. faecalis resulted in 3.9log 10 decrease in viable counts by exposure to 20 times the MIC of vancomycin. 3 The treatment of a sodA and sodB double mutant with 10 times the MIC of norfloxacin for 2 h reduced viable counts by 10-fold compared with the wild-type E. coli. 9 Previously, Kohanski et al. demonstrated that increased production of ROS by antibiotics leads to the destabilization of iron-sulfur clusters and the released Fe 2 þ produces hydroxyl radicals via the Fenton reaction. 2 Hydroxyl radicals have a critical role in bacterial killing by antibiotics, and the production of hydroxyl radicals is mediated by a metabolic response under antibiotic treatment, which involves the tricarboxylic acid (TCA) pathway and subsequent depletion of NADH. 2 The importance of the TCA cycle in ROSmediated killing by antibiotics was reassured in L. monocytogenes. 4 Unlike the TCA cycle of E. coli, L. monocytogenes has noncyclic TCA pathway lacking a-ketoglutarate dehydrogenase, oxidative stress mutants, including Dsod and Dfri mutants, did not affect lethal kinetics by bactericidal antibiotics presumably due to the different TCA cycle. 4 As the genome sequence of C. jejuni demonstrates the presence of all genes responsible for the TCA cycle, 15 C. jejuni would adopt the ROS-mediated killing mechanism similar to E. coli. However, the presence of different ROS-detoxifying enzymes and regulatory mechanisms of oxidative stress resistance still propose C. jejuni may have a unique mechanism for ROS-mediated killing by antibiotics.
On the basis of our findings and previous reports, the effect of oxidative stress defense on antibiotic lethality may vary in different bacterial species. As the sole catalase and superoxide dismutase in C. jejuni, KatA and SodB contribute to C. jejuni's resistance to ciprofloxacin and rifampicin. To the best of our knowledge, this is the first report demonstrating the implication of oxidative stress defense in the antibiotic resistance of Campylobacter. At this stage, the elucidation of molecular details associated with the ROSmediated lethal mechanism in Campylobacter still awaits future studies. Figure 1 Viability of the wild-type (WT; C. jejuni NCTC 11168), sodB mutant (sodB), katA mutant (katA), sodB and katA double mutant (sodB katA), the sodB complementation strain (sodB-C) and the katA complementation strain (katA-C) after exposure to 10 times the MICs of ciprofloxacin (a) and rifampicin (b). The viability was calculated as CFU after antibiotic treatment was divided by CFU before the treatment. The results show the means and s.d. of three independent experiments. The statistical significance between the WT and the mutants was determined by two-way analysis of variance with Bonferroni's post-test using Prism software (version 5.01; Graphpad software Inc., La Jolla, CA, USA). *Po0.05, **Po0.01, ***Po0.001.
